Page 3 - Technology Validation News Today

The Relief Stent in March secured its 510k clearance from the FDA, allowing it to be marketed in the U.S. for patients suffering from kidney stones and other issues causing difficulty draining the kidney.

Relief™ Stent, a new urinary stent invented by Lee Ponsky, MD, in collaboration with Dean Secrest, secured FDA 510k clearance, which means it can be marketed

The Relief Stent in March secured its 510k clearance from the U.S. Food and Drug Administration, allowing it to be marketed in the United States for patients suffering from kidney stones and other issues causing difficulty draining the kidney.

Eni's subsidiary Plenitude will invest in the developer of the W2Power technology for floating wind power EnerOcean.

Enis subsidiary Plenitude will invest in the developer of the W2Power technology for floating wind power EnerOcean.

Plenitude (Eni) has announced that it is to invest in EnerOcean, the Spanish developer of the W2Power technology for floating wind power. The deal is structured as a long-term partnership focused on the deployment of the W2Power technology as a lead contender for floating wind power developments worldwide.

Italian oil and gas major Eni will, through its energy transition unit Plenitude, invest in EnerOcean S.L., the Spanish developer of the W2Power technology for floating wind power.

Italian oil and gas company Eni's renewable energy unit Plentitude said Friday it would invest in EnerOcean S.L., the Spanish…

With support from State of Ohio’s Technology Validation and Start-up Fund Case Western Reserve University and NeoIndicate LLC have signed an exclusive

The agreement is with a Lorain County company, NeoIndicate LLC. The imaging agent, discovered and developed at Case Western Reserve University's School of Medicine, 'fluorescently tags tumor cells to guide neurosurgeons to a more precise and complete surgical removal of glioblastoma and other malignant brain tumors,' the university said.